Cargando…
Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic
BACKGROUND: The COVID-19 pandemic has affected healthcare systems, professionals and patients around the world. At the same time, the burden of cerebrovascular events is considerable. Worldwide, more than one million deaths per year are due to cerebrovascular events, which are the second most freque...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402989/ https://www.ncbi.nlm.nih.gov/pubmed/32834715 http://dx.doi.org/10.1007/s11940-020-00634-4 |
_version_ | 1783566870472818688 |
---|---|
author | Padlina, G Bellwald, S Maurer, A Heldner, MR |
author_facet | Padlina, G Bellwald, S Maurer, A Heldner, MR |
author_sort | Padlina, G |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic has affected healthcare systems, professionals and patients around the world. At the same time, the burden of cerebrovascular events is considerable. Worldwide, more than one million deaths per year are due to cerebrovascular events, which are the second most frequent cause of death and the main cause of long-term disability in Europe. To approach the challenges of the COVID-19 pandemic and secondary cerebrovascular prevention: CONCLUSION: We recommend: (1) As in normal times, during the COVID-19 pandemic wave, patients need to seek urgent medical attention in case of any acute cerebrovascular event. This will assure they receive needed rapid cerebrovascular secondary prevention in addition to acute intravenous and endovascular reperfusion strategies. (2) As in normal times, during the COVID-19 pandemic wave, it is of utmost importance that patients adhere to their individual recommendations for secondary prevention. (3) Optimal secondary but also primary cerebrovascular prevention might reduce the burden of COVID-19 now and during potential subsequent waves. (4) Patients with cerebrovascular disease should strictly adhere to advice concerning the pandemic provided by their governments and to pandemic-related recommendations for them as individuals expressed by their treating physicians. |
format | Online Article Text |
id | pubmed-7402989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-74029892020-08-05 Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic Padlina, G Bellwald, S Maurer, A Heldner, MR Curr Treat Options Neurol Reflections from the COVID Pandemic (A Iranzo and M Rosenfeld, Section Editors) BACKGROUND: The COVID-19 pandemic has affected healthcare systems, professionals and patients around the world. At the same time, the burden of cerebrovascular events is considerable. Worldwide, more than one million deaths per year are due to cerebrovascular events, which are the second most frequent cause of death and the main cause of long-term disability in Europe. To approach the challenges of the COVID-19 pandemic and secondary cerebrovascular prevention: CONCLUSION: We recommend: (1) As in normal times, during the COVID-19 pandemic wave, patients need to seek urgent medical attention in case of any acute cerebrovascular event. This will assure they receive needed rapid cerebrovascular secondary prevention in addition to acute intravenous and endovascular reperfusion strategies. (2) As in normal times, during the COVID-19 pandemic wave, it is of utmost importance that patients adhere to their individual recommendations for secondary prevention. (3) Optimal secondary but also primary cerebrovascular prevention might reduce the burden of COVID-19 now and during potential subsequent waves. (4) Patients with cerebrovascular disease should strictly adhere to advice concerning the pandemic provided by their governments and to pandemic-related recommendations for them as individuals expressed by their treating physicians. Springer US 2020-08-05 2020 /pmc/articles/PMC7402989/ /pubmed/32834715 http://dx.doi.org/10.1007/s11940-020-00634-4 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Reflections from the COVID Pandemic (A Iranzo and M Rosenfeld, Section Editors) Padlina, G Bellwald, S Maurer, A Heldner, MR Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic |
title | Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic |
title_full | Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic |
title_fullStr | Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic |
title_full_unstemmed | Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic |
title_short | Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic |
title_sort | secondary cerebrovascular prevention in light of the covid-19 pandemic |
topic | Reflections from the COVID Pandemic (A Iranzo and M Rosenfeld, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402989/ https://www.ncbi.nlm.nih.gov/pubmed/32834715 http://dx.doi.org/10.1007/s11940-020-00634-4 |
work_keys_str_mv | AT padlinag secondarycerebrovascularpreventioninlightofthecovid19pandemic AT bellwalds secondarycerebrovascularpreventioninlightofthecovid19pandemic AT maurera secondarycerebrovascularpreventioninlightofthecovid19pandemic AT heldnermr secondarycerebrovascularpreventioninlightofthecovid19pandemic |